Mucinex Recall Issued Over Acetaminophen Labeling Error

About 1.5 million bottles of liquid Mucinex Fast-Max are being recalled due to manufacturing problems, where the back labels may not indicate that the drug contains acetaminophen and other ingredients.

The Mucinex Fast-Max recall was announced on Tuesday by RB (formerly Reckitt Benckiser), after the company confirmed a retailer’s report that the back label information did not match the front. While no illnesses or injuries have been linked to the recalled cold medications, this could cause problems for users taking other medications containing similar ingredients.

“This missing labeling could cause the consumer to be unaware of side effects and/or risks associated with the ingestion of certain product ingredients which include Acetaminophen, Dextromethorphan, Guaifenesin, Phenylephrine and/or Diphenhydramine,” the company’s announcement warns. “The voluntary recall is being issued nationwide as a precautionary measure to ensure our consumers have all relevant facts and warnings for the active ingredients contained in the bottle.”

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

The recall involves 135 lots of Mucinex Fast-Max Night-time Cold & Flu Liquid, Mucinex Fast-Max Cold & Sinus Liquid, Mucinex Fast-Max Severe Congestion & Cough Liquid, Mucinex Fast-Max Cold, Flu & Sore Throat Liquid, Mucinex Fast-Max Liquid Combination – Day Night Severe Cold and Night-Time Cold & Flu, and Mucinex Fast-Max Liquid combination packs – Daytime Severe Congestion & Cough Night-Time Cold & Flu. Full details, expiration dates and lot numbers can be found in the recall notice.

The recall comes amid increased concerns over the side effects of acetaminophen, which can include liver damage and even liver failure when excessive doses are received.

Acetaminophen is the most commonly used analgesic painkiller in the world, and is generally believed to be a safe medication. However, in recent years concerns have grown over the risk of liver damage from acetaminophen overdoses, which can result in liver failure and the need for a liver transplant. It has also been liked to dangerous skin reactions, like Stephens-Johnson Syndrome.

The FDA has indicated that Tylenol and other drugs containing acetaminophen may be responsible for more than 50,000 emergency room visits each year, including 25,000 hospitalizations and over 450 deaths annually.

In recent years, efforts have been ramped up to bring the risk of acetaminophen overdose to the public’s attention and to reduce the amount of liver injury cases linked to the popular analgesic, which is also found in other pain killers and a number of cold medications..

A growing number of Tylenol lawsuits are being pursued throughout the United States, alleging that the drug maker has withheld important acetaminophen safety information from the public for decades.

RB is urging consumers to safely dispose of the recalled cold medications by mixing them with an unpalatable substance like kitty litter or used coffee grounds, placing the mixture in a sealed plastic bag or other container and throwing it away in the household trash.

Consumers with questions can contact the company by calling 1-888-943-4215 or by visiting the website at www.mucinexe.com/recall.

1 Comments

  • AngelicaMay 3, 2016 at 4:18 pm

    I bought this medicine and was not warned about the recall by the store. I have been taking it and I am concerned. If someone can please contact me it would be great. Thank you.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

First Gardasil Lawsuit Set For Trial To Begin October 7th in California State Court
First Gardasil Lawsuit Set For Trial To Begin October 7th in California State Court (Posted today)

The first Gardasil lawsuit will go to trial in California state court in October, as a group of cases at the federal level continue to be developed for future bellwether trials that are unlikely to begin until late 2025 or early 2026.

Tepezza Settlement Talks For Hearing Loss Claims Will Commence Next Month
Tepezza Settlement Talks For Hearing Loss Claims Will Commence Next Month (Posted today)

Parties have been directed to meet quarterly for mediation sessions, which will explore the potential for Tepezza hearing loss settlements, as the talks leading up to the first bellwether trials, slated to begin in March 2026.

Judge Allows New Ozempic, Wegovy Lawsuits To Be Directly Filed in Federal MDL
Judge Allows New Ozempic, Wegovy Lawsuits To Be Directly Filed in Federal MDL (Posted yesterday)

A federal judge is allowing those presenting Ozempic, Wegovy and Mounjaro lawsuits to file them directly with the MDL court to speed up the process of preparing the cases for potential future bellwether trials.